Anise oil is the common name for the essential oil obtained from the dried ripe fruits of the plant Pimpinella anisum L, which belongs to the Apiaceae (Umbelliferae) botanical family. The material of interest for medicinal use is the fruit (the whole cremocarp), generally entire, having an odor reminiscent of anethole. A small fragment of the thin, rigid, slightly curved pedicel is frequently attached. This herbal substance is administered in liquid or, after crushing, in solid dosage forms. Pimpinella anisum L., fructus (aniseed) is characterized by a content of essential oil (anise oil) not lower than 20 mL per kg anhydrous fruit and its medicinal properties are mainly attributed to its content of essential oil. Other constituents include flavonol glycosides, phenolic acid, a phenolic glycoside, furocoumarins, (mainly bergapten), hydroxycoumarins, (mainly umbelliferone) and fixed oil and lipids, (mainly constituted of petroselinic acid). Twelve new and 5 known glycosides of phenylpropanoids, including 4 stereoisomers of anethole glycol 2’-O-beta-D-glucopyranoside and 4 stereoisomers of 1’-(4-hydroxyphenyl)propane-1’,2’-diol 2’-O-beta-glucopyranoside were extracted from the water-soluble portion of the methanolic extract of aniseed, together with anethole glycols and guaiacyl glycerol. The isolation and characterization of eight 2-Cmethyl- D-erythritol glycosides and of twelve phenylpropanoid glycosides from the watersoluble portion of aniseed have been carried out.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
Please note: Due to the complexity and amount of studies regarding this compound—a Natural Health Product—increased cost is charged.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Anise, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.